Preventing Macular Edema with Preoperative Intravitreal  Bevacizumab in Diabetic Retinopathy Patients Undergoing  Phacoemulsification

Sidra Zafar Iqbal, Zafar Iqbal

Preventing Macular Edema with Preoperative Intravitreal Bevacizumab in Diabetic Retinopathy Patients Undergoing Phacoemulsification

Authors

Sidra Zafar Iqbal, Zafar Iqbal

Keywords:

Diabetic Retinopathy, Macular Edema, Bevacizumab, Phacoemulsification, Anti-VEGF Therapy, Visual Acuity, OCT

Abstract

Background: Patients with diabetic retinopathy who have phacoemulsification may face a higher riskof postoperative macular edema that can greatly affect the visual results.
Objective: To measure the ability of preoperative intravitreal bevacizumab to prevent postoperativemacular edema and improve visual outcomes in diabetic retinopathy patients attending phacoemulsification

References

1. Zhang R, Dong L, Yang Q, Liu Y, Li H, Zhou W, Wu H, Li Y, Li Y, Yu C, Wei W. (2022). Prophylactic interventions for preventing macular edema after cataract surgery in patients with diabetes: a Bayesian network meta-analysis of randomized controlled trials. EClinicalMedicine, 49

Downloads

Published

2026-05-05

How to Cite

Sidra Zafar Iqbal, Zafar Iqbal. (2026). Preventing Macular Edema with Preoperative Intravitreal Bevacizumab in Diabetic Retinopathy Patients Undergoing Phacoemulsification. International Journal of Pharmacy Research & Technology (IJPRT), 16(1), 2193–2198. Retrieved from https://ijprt.org/index.php/pub/article/view/1853